We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LZ:NASDAQLegalZoom.com, Inc. Analysis

Data as of 2026-06-14 - not real-time

$5.91

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

LegalZoom (LZ) is trading at $5.91, well below its 20‑day SMA of $6.16 and 50‑day SMA of $6.21, with the 200‑day SMA sitting at $8.35, indicating a bearish price trend. The MACD line ($-0.133) sits under its signal ($-0.091) and the RSI at 44 suggests neutral‑to‑weak momentum, while the current price hovers just above the identified support of $5.53 and well under the resistance of $6.76. Despite a high trailing P/E of 98.5 versus an industry average of 30.6, the forward P/E collapses to 7.13, reflecting a dramatic earnings acceleration (forward EPS $0.8285 vs trailing $0.06). A discounted cash‑flow model values the stock at $18.34, implying a 44% upside potential, and analysts’ target median price of $8.25 reinforces this undervaluation narrative. Fundamentally, the company posted 13% year‑over‑year revenue growth, maintains a strong gross margin of 66%, and generated $131 M of free cash flow, underscoring cash‑generating capacity. Recent Q1 results beat expectations, driven by premium subscription packages that are expanding recurring revenue streams. However, volatility is elevated at 54.7% over the past 30 days and beta is near 1.0, while trading volume has been on a downtrend, adding liquidity concerns. The balance sheet remains solid with $183 M cash versus $15 M debt, and a low debt‑to‑equity of 10.4. Overall, the stock sits at a strategic inflection point where technical weakness clashes with strong fundamentals and a sizable valuation gap, suggesting a nuanced short‑to‑medium‑term outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical indicators (price below SMAs, MACD bearish)
  • Q1 earnings beat and subscription‑driven revenue growth
  • Substantial upside implied by DCF versus current price

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E of 7.13 indicating earnings acceleration
  • Undervalued relative to DCF fair value and analyst targets
  • Strong cash flow generation and expanding recurring subscription base

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustainable business model with high gross margins
  • Potential regulatory and competitive pressures in the legal services space
  • Valuation convergence risk as market re‑prices growth expectations

Key Metrics & Analysis

Financial Health

Revenue Growth12.90%
Profit Margin1.46%
P/E Ratio98.5
ROE6.83%
ROA2.46%
Debt/Equity10.36
P/B Ratio7.0
Op. Cash Flow$174.8M
Free Cash Flow$131.2M
Industry P/E30.6

Technical Analysis

TrendBearish
RSI44.3
Support$5.53
Resistance$6.76
MA 20$6.16
MA 50$6.21
MA 200$8.35
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value$18.34
Target Price$8.50
Upside/Downside43.82%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.01
Volatility54.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.